GT Biopharma annual meeting elects all four directors, ratifies auditor

GT Biopharma, Inc.

Quorum: 691,084 shares (50.05%) represented at June 25 annual meeting.
All four directors elected: Breen (298,002 for), Shrotriya (295,782), Wendel (229,004), Casamento (266,456).
Ratification of Weinberg & Company as auditor: 579,726 for, 89,595 against, 21,763 abstain.
Non-binding advisory vote on executive compensation approved: 277,591 for, 47,062 against, 6,392 abstain, 360,039 broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.